Janine E. Polifka

1.9k total citations
31 papers, 1.2k citations indexed

About

Janine E. Polifka is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Janine E. Polifka has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 17 papers in Public Health, Environmental and Occupational Health and 6 papers in Molecular Biology. Recurrent topics in Janine E. Polifka's work include Pregnancy and Medication Impact (14 papers), Assisted Reproductive Technology and Twin Pregnancy (6 papers) and Prenatal Substance Exposure Effects (5 papers). Janine E. Polifka is often cited by papers focused on Pregnancy and Medication Impact (14 papers), Assisted Reproductive Technology and Twin Pregnancy (6 papers) and Prenatal Substance Exposure Effects (5 papers). Janine E. Polifka collaborates with scholars based in United States, Canada and Germany. Janine E. Polifka's co-authors include Jan M. Friedman, Margaret P Adam, S Alwan, Christina Chambers, Magdalene Dohil, Joseph M. Lam, Richard K. Miller, W.M. Generoso, Joe C. Rutledge and Gideon Koren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Obstetrics and Gynecology and Journal of the American Academy of Dermatology.

In The Last Decade

Janine E. Polifka

30 papers receiving 1.2k citations

Peers

Countries citing papers authored by Janine E. Polifka

Since Specialization

Citations

This map shows the geographic impact of Janine E. Polifka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janine E. Polifka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janine E. Polifka more than expected).

Fields of papers citing papers by Janine E. Polifka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janine E. Polifka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janine E. Polifka. The network helps show where Janine E. Polifka may publish in the future.

Co-authorship network of co-authors of Janine E. Polifka

This figure shows the co-authorship network connecting the top 25 collaborators of Janine E. Polifka. A scholar is included among the top collaborators of Janine E. Polifka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janine E. Polifka. Janine E. Polifka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of developmental risk information on medicines for inclusion on the WHO’s Essential Medicines List 2019 ·International Health ·Janine E. Polifka, (unknown), (unknown), Steven H. Lamm	2
2	Should pregnant women be included in phase IV clinical drug trials? 2015 ·American Journal of Obstetrics and Gynecology ·GERALD G. BRIGGS, Janine E. Polifka, Katherine L. Wisner, (unknown), Richard K. Miller, Anick Bérard, Gideon Koren, Alicia B. Forinash, Craig V. Towers	25
3	Is there an embryopathy associated with first‐trimester exposure to angiotensin‐converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence 2012 ·Birth Defects Research Part A Clinical and Molecular Teratology ·Janine E. Polifka	26
4	Reliability and validity of the 4‐item perceived stress scale among pregnant women: Results from the OTIS antidepressants study 2012 ·Research in Nursing & Health ·(unknown), Anick Bérard, Odile Sheehy, (unknown), (unknown), Christina Chambers, Adrienne Einarson, Diana Johnson, Kelly Kao, Gideon Koren, Brigitte Martin, Janine E. Polifka, Sara Riordan, Mark J. Roth, Sharon Voyer Lavigne, (unknown)	141
5	Evolving knowledge of the teratogenicity of medications in human pregnancy 2011 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·Margaret P Adam, Janine E. Polifka, Jan M. Friedman	235
6	Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases 2008 ·Journal of the American Academy of Dermatology ·Joseph M. Lam, Janine E. Polifka, Magdalene Dohil	59
7	Better data needed from pregnancy registries 2008 ·Birth Defects Research Part A Clinical and Molecular Teratology ·GERALD G. BRIGGS, Janine E. Polifka	12
8	Addendum: Sartan treatment during pregnancy 2005 ·Birth Defects Research Part A Clinical and Molecular Teratology ·Sura Alwan, Janine E. Polifka, Jan M. Friedman	4
9	A survey of pregnant women using isotretinoin 2005 ·Birth Defects Research Part A Clinical and Molecular Teratology ·Julia Robertson, Janine E. Polifka, (unknown), Christina Chambers, (unknown), Gideon Koren, Sharon Voyer Lavigne, (unknown), Richard K. Miller, John C. Carey	27
10	Angiotensin II receptor antagonist treatment during pregnancy 2005 ·Birth Defects Research Part A Clinical and Molecular Teratology ·S Alwan, Janine E. Polifka, Jan M. Friedman	132
11	Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs 2004 ·Birth Defects Research Part A Clinical and Molecular Teratology ·Anthony R. Scialli, (unknown), Christina Chambers, Jan M. Friedman, Carole A. Kimmel, Janine E. Polifka, Melissa S. Tassinari	31
12	Statement of the Public Affairs Committee of the Teratology Society on the fetal alcohol syndrome 2002 ·Teratology ·Jane Adams, (unknown), Harpal S. Buttar, Christina Chambers, T.F.X. Collins, George P. Daston, Karen Filkins, Thomas J. Flynn, John M. Graham, Kenneth Lyons Jones, Carole A. Kimmel, Edward J. Lammer, R. Librizzi, Joseph Mitala, Janine E. Polifka	13
13	Teratogen update: Azathioprine and 6‐mercaptopurine 2002 ·Teratology ·Janine E. Polifka, Jan M. Friedman	154
14	Update on new developments in the study of human teratogens 2002 ·Teratology ·Thomas H. Shepard, Robert L. Brent, Jan M. Friedman, Kenneth Lyons Jones, Richard K. Miller, Cynthia A. Moore, Janine E. Polifka	56
15	Developmental toxicity: web resources for evaluating risk in humans 2002 ·Toxicology ·Janine E. Polifka, Elaine M. Faustman	8
16	A call for action—prevention of fetal exposure to isotretinoin. a position paper by the organization of teratology information services public affairs committee 2001 ·Reproductive Toxicology ·Virginia Carver, (unknown), Gideon Koren, (unknown), (unknown), Julia Robertson, Janine E. Polifka, (unknown)	3
17	Clinical teratology: identifying teratogenic risks in humans 1999 ·Clinical Genetics ·Janine E. Polifka, Jan M. Friedman	30
18	Exposure to ethylene oxide during the early zygotic period induces skeletal anomalies in mouse fetuses 1996 ·Teratology ·Janine E. Polifka, Joe C. Rutledge, Gary L. Kimmel, Vicki L. Dellarco, W.M. Generoso	24
19	Clinical teratology counseling and consultation report: High dose β-carotene use during early pregnancy 1996 ·Teratology ·Janine E. Polifka, (unknown), (unknown), Jan M. Friedman	5
20	EFFECTS OF VITAMIN SUPPLEMENTATION ON THE OCCURRENCE OF NEURAL TUBE DEFECTS IN THE RAT 1987 ·Pediatric Research ·Janine E. Polifka, (unknown), Robert L. Brent	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact